Original Research

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Cheng JD, Chai LX, Zhao ZP, Hao YY, Li S

Cancer Management and Research 2020, 12:5641-5650

Published Date: 12 July 2020